Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
All people
Shengyuan Yu
Sort by Type
Date
Speaker
ePoster
P285
Rimegepant for the acute treatment of migraine – a phase 3, multicenter, open-label, long-term safety study in adults from China
Further involvements
ePoster
P017
Use of Rimegepant 75 mg for the acute treatment of migraine is associated with a reduction in monthly migraine days – a pooled analysis of 2 open-label trials
ePoster
P059
Depression and anxiety in Chinese patients hospitalized with primary headache – a cross-sectional multicenter study
Abstract lecture
AL011
Activation of CaMKII-α+ neurons in the ventrolateral orbitofrontal cortex exerts analgesic effect in a mouse model of triptan- associated medication overuse headache
ePoster
P285
Rimegepant for the acute treatment of migraine – a phase 3, multicenter, open-label, long-term safety study in adults from China
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy